Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... patients get inadequate relief. Current treatments consist of NSAIDs, selective Cox-2 inhibitors, opioids and other analgesics that are dosed daily and have various tolerability and ...
2009 NOV 23 ... to the in vitro results, a selection of compounds exhibiting moderate to high COX-2/COX-1 selectivity ratio (from weak COX-2 preferential inhibitors to compounds displaying a ...
2009 NOV 16 ... 111 River St., Hoboken, NJ 07030, USA. Keywords: Israel, Tel Aviv, COX-2 Inhibitors, Cyclooxygenase, Enzymes, Head and Neck Cancer, Head and Neck Carcinoma, Head and Neck ...
2009 NOV 23 ... activation. Stimulating the Wnt/beta-catenin pathway by both Wnt 3a and GSK-3beta inhibitors (LiCl and SB 216763), blocked aspirin-induced apoptosis and protected mitochondrial ...
2009 NOV 23 ... patients get inadequate relief. Current treatments consist of NSAIDs, selective Cox-2 inhibitors, opioids, and other analgesics that are dosed daily and have various tolerability and ...
2009 NOV 16 ... their study in American Journal of Managed Care (Impact of Compliance With Proton Pump Inhibitors on NSAID Treatment. American Journal of Managed Care, 2009;15(10):681-688). ...
2009 NOV 23 ... variety of organophosphorus compounds (OPCs). However, oximes themselves are also AChE inhibitors, albeit at higher concentrations, which is a major cause of their toxicity and may be a ...
2009 NOV 16 ... toxicity in a prevention trial have shifted focus away from these cyclooxygenase (COX) inhibitors to seek additional therapeutic targets in the prostaglandin pathway. Previously, the ...
2009 NOV 16 ... the second passage were cultured with or without IL-1 beta, dexamethasone (DEX), or COX inhibitors such as NS-398, meloxicam, and indomethacin. Reverse transcription-polymerase chain ...
2009 NOV 16 ... 19106-4404, USA. Keywords: United States, Los Angeles, Biotechnology, COX-2 Inhibitors, Cyclooxygenase, Cytokines, Enzymes, Experimental Design, Head and Neck Cancer, Head and ...
2009 NOV 16 ... New York, NY 10013, USA. Keywords: Germany, Frankfurt, Apoptosis, COX-2 Inhibitors, Celecoxib, Chromatography, Colon Cancer, Colon Carcinoma, Colorectal, Cyclooxygenase, ...
2009 NOV 17 ... series of iodinated indomethacin derivatives was synthesized, and evaluated as selective inhibitors of COX-2. Two candidate compounds ...
2009 NOV 16 ... play a critical role in the regulation of growth in epidermoid carcinoma and that their inhibitors may be of potential therapeutic importance." Agarwal and colleagues ...
